Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 4
2018 3
2019 6
2020 11
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Influenza vaccination: protecting the most vulnerable.
Tanner AR, Dorey RB, Brendish NJ, Clark TW. Tanner AR, et al. Eur Respir Rev. 2021 Jan 13;30(159):200258. doi: 10.1183/16000617.0258-2020. Print 2021 Mar 31. Eur Respir Rev. 2021. PMID: 33650528 Free PMC article. Review.
Treatment of influenza with neuraminidase inhibitors.
Beard KR, Brendish NJ, Clark TW. Beard KR, et al. Curr Opin Infect Dis. 2018 Dec;31(6):514-519. doi: 10.1097/QCO.0000000000000496. Curr Opin Infect Dis. 2018. PMID: 30320639 Review.
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, Clark T, Djukanovic R, Wilkinson TMA; Inhaled Interferon Beta COVID-19 Study Group. Monk PD, et al. Lancet Respir Med. 2021 Feb;9(2):196-206. doi: 10.1016/S2213-2600(20)30511-7. Epub 2020 Nov 12. Lancet Respir Med. 2021. PMID: 33189161 Free PMC article. Clinical Trial.
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
Clark TW, Beard KR, Brendish NJ, Malachira AK, Mills S, Chan C, Poole S, Ewings S, Cortes N, Nyimbili E, Presland L. Clark TW, et al. Lancet Respir Med. 2021 Apr;9(4):419-429. doi: 10.1016/S2213-2600(20)30469-0. Epub 2020 Dec 4. Lancet Respir Med. 2021. PMID: 33285143 Free PMC article. Clinical Trial.
Inflammatory phenotyping predicts clinical outcome in COVID-19.
Burke H, Freeman A, Cellura DC, Stuart BL, Brendish NJ, Poole S, Borca F, Phan HTT, Sheard N, Williams S, Spalluto CM, Staples KJ, Clark TW, Wilkinson TMA; REACT COVID investigators. Burke H, et al. Respir Res. 2020 Sep 22;21(1):245. doi: 10.1186/s12931-020-01511-z. Respir Res. 2020. PMID: 32962703 Free PMC article.
24 results